##fileformat=VCFv4.2
##fileDate=20210205
##reference=ftp://ftp.ncbi.nih.gov/genbank/genomes/Eukaryotes/vertebrates_mammals/Homo_sapiens/GRCh37/special_requests/GRCh37-lite.fa.gz
##source=CIViCpy_v1.1.3
##aboutURL=https://civicdb.org/help/evidence/overview
##INFO=<ID=GN,Number=1,Type=String,Description="HGNC Gene Symbol">
##INFO=<ID=VT,Number=1,Type=String,Description="CIViC Variant Name">
##INFO=<ID=CSQ,Number=.,Type=String,Description="Consequence annotations from CIViC. Format: Allele|Consequence|SYMBOL|Entrez Gene ID|Feature_type|Feature|HGVSc|HGVSp|CIViC Variant Name|CIViC Variant ID|CIViC Variant Aliases|CIViC HGVS|Allele Registry ID|ClinVar IDs|CIViC Variant Evidence Score|CIViC Entity Type|CIViC Entity ID|CIViC Entity URL|CIViC Entity Source|CIViC Entity Variant Origin|CIViC Entity Status|CIViC Entity Clinical Significance|CIViC Entity Direction|CIViC Entity Disease|CIViC Entity Drugs|CIViC Entity Drug Interaction Type|CIViC Evidence Phenotypes|CIViC Evidence Level|CIViC Evidence Rating|CIViC Assertion ACMG Codes|CIViC Assertion AMP Category|CIViC Assertion NCCN Guideline|CIVIC Assertion Regulatory Approval|CIVIC Assertion FDA Companion Test ">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
1	115258744	93	C	T	.	.	GN=NRAS;VT=G13D;CSQ=T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.38G>A||G13D|93|RS121434596&GLY13ASP|NM\x5F002524\x2E4\x3Ac\x2E38G\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGly13Asp&NC\x5F000001\x2E10\x3Ag\x2E115258744C\x3ET&ENST00000369535\x2E4\x3Ac\x2E38G\x3EA|CA123620|13901|5.0|evidence|21|https://civicdb.org/links/evidence/21|18375819_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Tanespimycin_(NCIt_ID_C37899)|||C|2|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.38G>A||G13D|93|RS121434596&GLY13ASP|NM\x5F002524\x2E4\x3Ac\x2E38G\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGly13Asp&NC\x5F000001\x2E10\x3Ag\x2E115258744C\x3ET&ENST00000369535\x2E4\x3Ac\x2E38G\x3EA|CA123620|13901|5.0|evidence|3840|https://civicdb.org/links/evidence/3840|24553387_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||
1	11187094	470	G	T	.	.	GN=MTOR;VT=F2108L;CSQ=T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6324C>A||F2108L|470|PHE2108LEU|ENST00000361445\x2E4\x3Ac\x2E6324C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11187094G\x3ET|CA338391533|NONE_FOUND|16.5|evidence|1110|https://civicdb.org/links/evidence/1110|25295501_(PubMed)|Somatic|accepted|Resistance|Supports|Thyroid_Gland_Carcinoma_(DOID_3963)|Everolimus_(NCIt_ID_C48387)|||C|5|||||,T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6324C>A||F2108L|470|PHE2108LEU|ENST00000361445\x2E4\x3Ac\x2E6324C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11187094G\x3ET|CA338391533|NONE_FOUND|16.5|evidence|1543|https://civicdb.org/links/evidence/1543|27279227_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Sirolimus_(NCIt_ID_C1212)|||D|4|||||
2	29445258	6	C	T	.	.	GN=ALK;VT=EML4-ALK_C1156Y;CSQ=T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|4046|https://civicdb.org/links/evidence/4046|27045755_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|841|https://civicdb.org/links/evidence/841|26698910_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Luminespib_(NCIt_ID_C71467)&Ceritinib_(NCIt_ID_C115112)&Crizotinib_(NCIt_ID_C74061)|Sequential||C|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|1346|https://civicdb.org/links/evidence/1346|24675041_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|4|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|7613|https://civicdb.org/links/evidence/7613|26698910_(PubMed)|Somatic|submitted|Resistance|Supports|Cancer_(DOID_162)|Crizotinib_(NCIt_ID_C74061)|||D|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|4042|https://civicdb.org/links/evidence/4042|23434628_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|8860|https://civicdb.org/links/evidence/8860|31628085_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ensartinib_(NCIt_ID_C102754)|||B|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|842|https://civicdb.org/links/evidence/842|26698910_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Lorlatinib_(NCIt_ID_C113655)|||C|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|7609|https://civicdb.org/links/evidence/7609|26698910_(PubMed)|Somatic|submitted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Alectinib_(NCIt_ID_C101790)&Brigatinib_(NCIt_ID_C98831)&Ceritinib_(NCIt_ID_C115112)&Lorlatinib_(NCIt_ID_C113655)|Substitutes||D|4|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|4043|https://civicdb.org/links/evidence/4043|21791641_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|None|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|4044|https://civicdb.org/links/evidence/4044|22235099_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|None|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|EML4\x2DALK\x20CYS1156TYR&RS1057519859|ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr|CA16602783|376340|29.0|evidence|236|https://civicdb.org/links/evidence/236|20979473_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|4|||||
3	10183693	764	GGA	G	.	.	GN=VHL;VT=E55FS_(c.163_164delGA);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.163_164delGA||E55FS_(c.163_164delGA)|764|GLU55FS&C\x2E163\x5F164DELGA|NP\x5F000542\x2E1\x3Ap\x2EGlu55fs&NC\x5F000003\x2E11\x3Ag\x2E10183694\x5F10183695del&ENST00000256474\x2E2\x3Ac\x2E163\x5F164delGA|CA645524641|NONE_FOUND|0.5|evidence|1828|https://civicdb.org/links/evidence/1828|10408776_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||E|2|||||
4	55599321	65	A	T	.	.	GN=KIT;VT=D816V;CSQ=T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|26|https://civicdb.org/links/evidence/26|16384925_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|4|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|1726|https://civicdb.org/links/evidence/1726|26464169_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Systemic_Mastocytosis_(DOID_349)||||B|4|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|7465|https://civicdb.org/links/evidence/7465|25317746_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Dasatinib_(NCIt_ID_C38713)&Imatinib_(NCIt_ID_C62035)|Substitutes||C|2|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|1725|https://civicdb.org/links/evidence/1725|27355533_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Systemic_Mastocytosis_(DOID_349)|Midostaurin_(NCIt_ID_C1872)|||B|4|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|8361|https://civicdb.org/links/evidence/8361|16434489_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|8360|https://civicdb.org/links/evidence/8360|16434489_(PubMed)|Somatic|submitted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|4|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|8362|https://civicdb.org/links/evidence/8362|16434489_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|4|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|4163|https://civicdb.org/links/evidence/4163|19039322_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|None|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|4160|https://civicdb.org/links/evidence/4160|24205792_(PubMed)|Somatic|submitted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||D|None|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|2451|https://civicdb.org/links/evidence/2451|14645423_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|4159|https://civicdb.org/links/evidence/4159|18986703_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Dasatinib_(NCIt_ID_C38713)|||C|None|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|6956|https://civicdb.org/links/evidence/6956|19164557_(PubMed)|Somatic|submitted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||E|2|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|4162|https://civicdb.org/links/evidence/4162|16434489_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|None|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET|CA123513|13852|67.0|evidence|4161|https://civicdb.org/links/evidence/4161|19039322_(PubMed)|Somatic|submitted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||D|None|||||
5	170837547	87	G	GTCTG	.	.	GN=NPM1;VT=W288FS;CSQ=TCTG|frameshift_elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|TRP288FS&NPM1\x2DA&RS587776806|NM\x5F002520\x2E6\x3Ac\x2E860\x5F863dupTCTG&NC\x5F000005\x2E9\x3Ag\x2E170837544\x5F170837547dupTCTG&NP\x5F002511\x2E1\x3Ap\x2ETrp288Cysfs&ENST00000517671\x2E1\x3Ac\x2E860\x5F863dupTCTG|CA280199|13998|43.75|evidence|109|https://civicdb.org/links/evidence/109|21067377_(PubMed)|Somatic|accepted|Positive|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|4|||||,TCTG|frameshift_elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|TRP288FS&NPM1\x2DA&RS587776806|NM\x5F002520\x2E6\x3Ac\x2E860\x5F863dupTCTG&NC\x5F000005\x2E9\x3Ag\x2E170837544\x5F170837547dupTCTG&NP\x5F002511\x2E1\x3Ap\x2ETrp288Cysfs&ENST00000517671\x2E1\x3Ac\x2E860\x5F863dupTCTG|CA280199|13998|43.75|evidence|121|https://civicdb.org/links/evidence/121|21067377_(PubMed)|Somatic|accepted|Positive|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|4|||||,TCTG|frameshift_elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|TRP288FS&NPM1\x2DA&RS587776806|NM\x5F002520\x2E6\x3Ac\x2E860\x5F863dupTCTG&NC\x5F000005\x2E9\x3Ag\x2E170837544\x5F170837547dupTCTG&NP\x5F002511\x2E1\x3Ap\x2ETrp288Cysfs&ENST00000517671\x2E1\x3Ac\x2E860\x5F863dupTCTG|CA280199|13998|43.75|evidence|153|https://civicdb.org/links/evidence/153|15659725_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Induction_Therapy_(NCIt_ID_C158876)|||E|3|||||,TCTG|frameshift_elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|TRP288FS&NPM1\x2DA&RS587776806|NM\x5F002520\x2E6\x3Ac\x2E860\x5F863dupTCTG&NC\x5F000005\x2E9\x3Ag\x2E170837544\x5F170837547dupTCTG&NP\x5F002511\x2E1\x3Ap\x2ETrp288Cysfs&ENST00000517671\x2E1\x3Ac\x2E860\x5F863dupTCTG|CA280199|13998|43.75|evidence|152|https://civicdb.org/links/evidence/152|21719597_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|NSC348884|||D|3|||||
6	152419926	47	A	G	.	.	GN=ESR1;VT=D538G;CSQ=G|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1613A>G||D538G|47|ASP538GLY|ENST00000206249\x2E3\x3Ac\x2E1613A\x3EG&NC\x5F000006\x2E11\x3Ag\x2E152419926A\x3EG|CA366085705|NONE_FOUND|18.0|evidence|243|https://civicdb.org/links/evidence/243|24185512_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Hormone_Therapy_(NCIt_ID_C15445)|||D|3|||||,G|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1613A>G||D538G|47|ASP538GLY|ENST00000206249\x2E3\x3Ac\x2E1613A\x3EG&NC\x5F000006\x2E11\x3Ag\x2E152419926A\x3EG|CA366085705|NONE_FOUND|18.0|evidence|291|https://civicdb.org/links/evidence/291|24185510_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Fulvestrant_(NCIt_ID_C1379)&Tamoxifen_(NCIt_ID_C62078)|Substitutes||D|5|||||,G|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1613A>G||D538G|47|ASP538GLY|ENST00000206249\x2E3\x3Ac\x2E1613A\x3EG&NC\x5F000006\x2E11\x3Ag\x2E152419926A\x3EG|CA366085705|NONE_FOUND|18.0|evidence|4813|https://civicdb.org/links/evidence/4813|27269946_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Palbociclib_(NCIt_ID_C49176)|||C|None|||||,G|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1613A>G||D538G|47|ASP538GLY|ENST00000206249\x2E3\x3Ac\x2E1613A\x3EG&NC\x5F000006\x2E11\x3Ag\x2E152419926A\x3EG|CA366085705|NONE_FOUND|18.0|evidence|4814|https://civicdb.org/links/evidence/4814|27556863_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Breast_Cancer_(DOID_1612)|Letrozole_(NCIt_ID_C1527)&Palbociclib_(NCIt_ID_C49176)|Combination||B|2|||||
7	140453136	12	A	T	.	.	GN=BRAF;VT=V600E;CSQ=T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|106|https://civicdb.org/links/evidence/106|24396464_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|6123|https://civicdb.org/links/evidence/6123|29431699_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2125|https://civicdb.org/links/evidence/2125|16424035_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|MEK_Inhibitor_PD0325901_(NCIt_ID_C52195)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7156|https://civicdb.org/links/evidence/7156|20008640_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7612|https://civicdb.org/links/evidence/7612|31566309_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Binimetinib_(NCIt_ID_C84865)&Encorafenib_(NCIt_ID_C98283)&Cetuximab_(NCIt_ID_C1723)|Combination||A|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|8507|https://civicdb.org/links/evidence/8507|22180495_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Erlotinib_(NCIt_ID_C65530)&Vemurafenib_(NCIt_ID_C64768)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2135|https://civicdb.org/links/evidence/2135|22663011_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Trametinib_(NCIt_ID_C77908)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2121|https://civicdb.org/links/evidence/2121|19571295_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Oxaliplatin_(NCIt_ID_C1181)&Bevacizumab_(NCIt_ID_C2039)&Capecitabine_(NCIt_ID_C1794)|Combination||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3771|https://civicdb.org/links/evidence/3771|24725538_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Glioblastoma_(DOID_3068)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2136|https://civicdb.org/links/evidence/2136|17911174_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Cancer_(DOID_1781)|MEK_Inhibitor_CI-1040_(NCIt_ID_C2670)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|82|https://civicdb.org/links/evidence/82|24586605_(PubMed)|Somatic|accepted|Poor_Outcome|Does_Not_Support|Melanoma_(DOID_1909)||||B|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3781|https://civicdb.org/links/evidence/3781|23733758_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2130|https://civicdb.org/links/evidence/2130|16424035_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Selumetinib_(NCIt_ID_C66939)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|8952|https://civicdb.org/links/evidence/8952|29463802_(PubMed)|Somatic|submitted|Resistance|Supports|Diffuse_Large_B-cell_Lymphoma_(DOID_0050745)|Venetoclax_(NCIt_ID_C103147)|||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2503|https://civicdb.org/links/evidence/2503|21882184_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1408|https://civicdb.org/links/evidence/1408|22281684_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Gefitinib_(NCIt_ID_C1855)&Vemurafenib_(NCIt_ID_C64768)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2132|https://civicdb.org/links/evidence/2132|21107323_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|89|https://civicdb.org/links/evidence/89|19001320_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Sorafenib_(NCIt_ID_C61948)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1749|https://civicdb.org/links/evidence/1749|20818844_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|816|https://civicdb.org/links/evidence/816|25989278_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Cetuximab_(NCIt_ID_C1723)|Substitutes||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3758|https://civicdb.org/links/evidence/3758|25399551_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3760|https://civicdb.org/links/evidence/3760|18458053_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Cancer_(DOID_1781)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2118|https://civicdb.org/links/evidence/2118|19603024_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2115|https://civicdb.org/links/evidence/2115|19001320_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Cetuximab_(NCIt_ID_C1723)|Substitutes||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7077|https://civicdb.org/links/evidence/7077|25527633_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Dual_IGF-1R/InsR_Inhibitor_BMS-754807_(NCIt_ID_C74043)|||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7191|https://civicdb.org/links/evidence/7191|29948154_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Pediatric_Low-grade_Glioma_(DOID_0080830)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|98|https://civicdb.org/links/evidence/98|22180495_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Bevacizumab_(NCIt_ID_C2039)&Capecitabine_(NCIt_ID_C1794)&Vemurafenib_(NCIt_ID_C64768)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|5960|https://civicdb.org/links/evidence/5960|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2133|https://civicdb.org/links/evidence/2133|21107320_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7583|https://civicdb.org/links/evidence/7583|31513482_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Langerhans_Cell_Sarcoma_(DOID_7146)|Vemurafenib_(NCIt_ID_C64768)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2145|https://civicdb.org/links/evidence/2145|22492957_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|High_Grade_Glioma_(DOID_3070)|Selumetinib_(NCIt_ID_C66939)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|104|https://civicdb.org/links/evidence/104|24388723_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Melanoma_(DOID_1909)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|102|https://civicdb.org/links/evidence/102|24354346_(PubMed)|Somatic|accepted|Poor_Outcome|Does_Not_Support|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2119|https://civicdb.org/links/evidence/2119|19603018_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3768|https://civicdb.org/links/evidence/3768|23278307_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Hairy_Cell_Leukemia_(DOID_285)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2894|https://civicdb.org/links/evidence/2894|19001320_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Sorafenib_(NCIt_ID_C61948)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1902|https://civicdb.org/links/evidence/1902|27729313_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)&Vemurafenib_(NCIt_ID_C64768)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1428|https://civicdb.org/links/evidence/1428|23549875_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|GDC-0879&Dactolisib_(NCIt_ID_C74072)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3775|https://civicdb.org/links/evidence/3775|23729178_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)|Dasatinib_(NCIt_ID_C38713)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|5961|https://civicdb.org/links/evidence/5961|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Anaplastic_Carcinoma_(DOID_0080522)|Pertuzumab_(NCIt_ID_C38692)&Vemurafenib_(NCIt_ID_C64768)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1414|https://civicdb.org/links/evidence/1414|24987354_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)|Vemurafenib_(NCIt_ID_C64768)|||C|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1141|https://civicdb.org/links/evidence/1141|23934108_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Cobimetinib_(NCIt_ID_C68923)|||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1699|https://civicdb.org/links/evidence/1699|24997557_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Multiple_Myeloma_(DOID_9538)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|91|https://civicdb.org/links/evidence/91|23524406_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dabrafenib_(NCIt_ID_C82386)|||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1698|https://civicdb.org/links/evidence/1698|24997557_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Multiple_Myeloma_(DOID_9538)|Vemurafenib_(NCIt_ID_C64768)|||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7157|https://civicdb.org/links/evidence/7157|21502544_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3749|https://civicdb.org/links/evidence/3749|24463458_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|994|https://civicdb.org/links/evidence/994|24947927_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Melanoma_(DOID_1909)|MEK_Inhibitor_RO4987655_(NCIt_ID_C82696)|||B|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|656|https://civicdb.org/links/evidence/656|25024077_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|96|https://civicdb.org/links/evidence/96|23845441_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Pictilisib_Bismesylate_(NCIt_ID_C82380)&PLX4720|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3784|https://civicdb.org/links/evidence/3784|21185263_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Carcinoma_(DOID_3963)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|107|https://civicdb.org/links/evidence/107|21594703_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|5904|https://civicdb.org/links/evidence/5904|25435907_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Trametinib_Dimethyl_Sulfoxide_(NCIt_ID_C152711)&Dabrafenib_(NCIt_ID_C82386)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1405|https://civicdb.org/links/evidence/1405|26460303_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3738|https://civicdb.org/links/evidence/3738|19603018_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3779|https://civicdb.org/links/evidence/3779|26286452_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Clear_Cell_Sarcoma_(DOID_4233)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2124|https://civicdb.org/links/evidence/2124|16273091_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|MEK_Inhibitor_PD0325901_(NCIt_ID_C52195)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|9018|https://civicdb.org/links/evidence/9018|27460442_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)|Vemurafenib_(NCIt_ID_C64768)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2362|https://civicdb.org/links/evidence/2362|19903786_(PubMed)|Somatic|accepted|Poor_Outcome|Does_Not_Support|Colorectal_Cancer_(DOID_9256)||||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1552|https://civicdb.org/links/evidence/1552|27404270_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3017|https://civicdb.org/links/evidence/3017|27283860_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||A|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3782|https://civicdb.org/links/evidence/3782|26200454_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Vemurafenib_(NCIt_ID_C64768)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3777|https://civicdb.org/links/evidence/3777|25524464_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Childhood_Pilocytic_Astrocytoma_(DOID_6812)|Vemurafenib_(NCIt_ID_C64768)|||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1940|https://civicdb.org/links/evidence/1940|27302369_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3739|https://civicdb.org/links/evidence/3739|25666295_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|FOLFOX-4_Regimen_(NCIt_ID_C63590)&Cetuximab_(NCIt_ID_C1723)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7454|https://civicdb.org/links/evidence/7454|172039_(ASCO)|Somatic|submitted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|8646|https://civicdb.org/links/evidence/8646|19571295_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Oxaliplatin_(NCIt_ID_C1181)&Bevacizumab_(NCIt_ID_C2039)&Capecitabine_(NCIt_ID_C1794)&Cetuximab_(NCIt_ID_C1723)|Combination||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3776|https://civicdb.org/links/evidence/3776|26865419_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colon_Cancer_(DOID_219)|Regorafenib_(NCIt_ID_C78204)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2126|https://civicdb.org/links/evidence/2126|21343559_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2122|https://civicdb.org/links/evidence/2122|15781657_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Sorafenib_(NCIt_ID_C61948)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3759|https://civicdb.org/links/evidence/3759|19671763_(PubMed)|Somatic|submitted|Resistance|Supports|Melanoma_(DOID_1909)|Dasatinib_(NCIt_ID_C38713)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|8040|https://civicdb.org/links/evidence/8040|31937621_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Cancer_(DOID_1781)|Ponatinib_(NCIt_ID_C95777)&PLX4720|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1430|https://civicdb.org/links/evidence/1430|27048246_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Neuroendocrine_Tumor_(DOID_0050626)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)&Vemurafenib_(NCIt_ID_C64768)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|80|https://civicdb.org/links/evidence/80|24570209_(PubMed)|Somatic|accepted|Positive|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3754|https://civicdb.org/links/evidence/3754|24616537_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3741|https://civicdb.org/links/evidence/3741|22448344_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2144|https://civicdb.org/links/evidence/2144|20806365_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|High_Grade_Glioma_(DOID_3070)|Selumetinib_(NCIt_ID_C66939)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|5958|https://civicdb.org/links/evidence/5958|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Vemurafenib_(NCIt_ID_C64768)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|99|https://civicdb.org/links/evidence/99|22180495_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||D|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1005|https://civicdb.org/links/evidence/1005|26678033_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dactolisib_(NCIt_ID_C74072)&Selumetinib_(NCIt_ID_C66939)|Combination||D|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3773|https://civicdb.org/links/evidence/3773|25353071_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3746|https://civicdb.org/links/evidence/3746|21107323_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1591|https://civicdb.org/links/evidence/1591|27460442_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|95|https://civicdb.org/links/evidence/95|24583796_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3742|https://civicdb.org/links/evidence/3742|26287849_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7485|https://civicdb.org/links/evidence/7485|31151904_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Glioma|Selumetinib_(NCIt_ID_C66939)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2146|https://civicdb.org/links/evidence/2146|22735384_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Dabrafenib_(NCIt_ID_C82386)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3745|https://civicdb.org/links/evidence/3745|21107320_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|5906|https://civicdb.org/links/evidence/5906|26687137_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Irinotecan_(NCIt_ID_C62040)&Panitumumab_(NCIt_ID_C1857)&Vemurafenib_(NCIt_ID_C64768)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|6938|https://civicdb.org/links/evidence/6938|25265492_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|97|https://civicdb.org/links/evidence/97|23812671_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Nutlin-3&PLX4720|Combination||D|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3756|https://civicdb.org/links/evidence/3756|22241959_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2127|https://civicdb.org/links/evidence/2127|20818844_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|126|https://civicdb.org/links/evidence/126|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3788|https://civicdb.org/links/evidence/3788|24335681_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Malignant_Peripheral_Nerve_Sheath_Tumor_(DOID_5940)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|6124|https://civicdb.org/links/evidence/6124|29431699_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Adenocarcinoma_(DOID_0050861)|Panitumumab_(NCIt_ID_C1857)&Trametinib_(NCIt_ID_C77908)|Combination||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|8033|https://civicdb.org/links/evidence/8033|31937621_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Cancer_(DOID_1781)|Ponatinib_(NCIt_ID_C95777)&PLX4720|Combination||D|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3755|https://civicdb.org/links/evidence/3755|26557775_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1413|https://civicdb.org/links/evidence/1413|25589621_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Vemurafenib_(NCIt_ID_C64768)|Combination||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1406|https://civicdb.org/links/evidence/1406|22608338_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Dabrafenib_(NCIt_ID_C82386)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|5902|https://civicdb.org/links/evidence/5902|28480077_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Trametinib_Dimethyl_Sulfoxide_(NCIt_ID_C152711)&Dabrafenib_(NCIt_ID_C82386)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3787|https://civicdb.org/links/evidence/3787|26490654_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Serous_Carcinoma_(DOID_0050933)|Vemurafenib_(NCIt_ID_C64768)|||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3790|https://civicdb.org/links/evidence/3790|27520988_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Malignant_Conjunctival_Melanoma_(DOID_1751)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3753|https://civicdb.org/links/evidence/3753|20551065_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3767|https://civicdb.org/links/evidence/3767|23300174_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Hairy_Cell_Leukemia_(DOID_285)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3785|https://civicdb.org/links/evidence/3785|26456083_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Carcinoma_(DOID_3963)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2117|https://civicdb.org/links/evidence/2117|19603024_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Oxaliplatin_(NCIt_ID_C1181)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|79|https://civicdb.org/links/evidence/79|21594703_(PubMed)|Somatic|accepted|Positive|Supports|Thyroid_Gland_Cancer_(DOID_1781)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|90|https://civicdb.org/links/evidence/90|24576830_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|6178|https://civicdb.org/links/evidence/6178|28891408_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3757|https://civicdb.org/links/evidence/3757|25524477_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3789|https://civicdb.org/links/evidence/3789|25209580_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Histiocytoma_(DOID_4231)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2139|https://civicdb.org/links/evidence/2139|21351275_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Cancer_(DOID_1781)|RDEA_119|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|463|https://civicdb.org/links/evidence/463|23612012_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Multiple_Myeloma_(DOID_9538)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7761|https://civicdb.org/links/evidence/7761|145877_(ASCO)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)|Dabrafenib_(NCIt_ID_C82386)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|6045|https://civicdb.org/links/evidence/6045|26287849_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Anaplastic_Carcinoma_(DOID_0080522)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2128|https://civicdb.org/links/evidence/2128|16424035_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1579|https://civicdb.org/links/evidence/1579|26352686_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Hairy_Cell_Leukemia_(DOID_285)|Vemurafenib_(NCIt_ID_C64768)|||B|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2129|https://civicdb.org/links/evidence/2129|18172275_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Selumetinib_(NCIt_ID_C66939)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3780|https://civicdb.org/links/evidence/3780|24888229_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|103|https://civicdb.org/links/evidence/103|24594804_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3736|https://civicdb.org/links/evidence/3736|19884556_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3769|https://civicdb.org/links/evidence/3769|25815361_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Hairy_Cell_Leukemia_(DOID_285)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1398|https://civicdb.org/links/evidence/1398|24508103_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3744|https://civicdb.org/links/evidence/3744|27532222_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Anaplastic_Carcinoma_(DOID_0080522)|Vemurafenib_(NCIt_ID_C64768)|||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3752|https://civicdb.org/links/evidence/3752|26070258_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3770|https://civicdb.org/links/evidence/3770|27116997_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Hairy_Cell_Leukemia_(DOID_285)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1409|https://civicdb.org/links/evidence/1409|21639808_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Vemurafenib_(NCIt_ID_C64768)|||A|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|5959|https://civicdb.org/links/evidence/5959|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|6940|https://civicdb.org/links/evidence/6940|23020132_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3774|https://civicdb.org/links/evidence/3774|23489023_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7264|https://civicdb.org/links/evidence/7264|169315_(ASCO)|Somatic|submitted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3761|https://civicdb.org/links/evidence/3761|25706985_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|86|https://civicdb.org/links/evidence/86|24576830_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Melanoma_(DOID_1909)|MEK_Inhibitor_PD0325901_(NCIt_ID_C52195)&Trametinib_(NCIt_ID_C77908)|Substitutes||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2131|https://civicdb.org/links/evidence/2131|16424035_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Trametinib_(NCIt_ID_C77908)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1410|https://civicdb.org/links/evidence/1410|22356324_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2143|https://civicdb.org/links/evidence/2143|19010912_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|MEK_Inhibitor_PD0325901_(NCIt_ID_C52195)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|105|https://civicdb.org/links/evidence/105|21594703_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3740|https://civicdb.org/links/evidence/3740|26989027_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3778|https://civicdb.org/links/evidence/3778|26579623_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Ganglioglioma_(DOID_5078)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|5903|https://civicdb.org/links/evidence/5903|28078132_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Trametinib_Dimethyl_Sulfoxide_(NCIt_ID_C152711)&Dabrafenib_(NCIt_ID_C82386)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3827|https://civicdb.org/links/evidence/3827|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3772|https://civicdb.org/links/evidence/3772|24821190_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Pilocytic_Astrocytoma_(DOID_4851)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|6975|https://civicdb.org/links/evidence/6975|29072975_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Anaplastic_Carcinoma_(DOID_0080522)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3748|https://civicdb.org/links/evidence/3748|16424035_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3766|https://civicdb.org/links/evidence/3766|22621641_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Hairy_Cell_Leukemia_(DOID_285)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3783|https://civicdb.org/links/evidence/3783|26776917_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7260|https://civicdb.org/links/evidence/7260|168986_(ASCO)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Binimetinib_(NCIt_ID_C84865)&Encorafenib_(NCIt_ID_C98283)&Cetuximab_(NCIt_ID_C1723)|Combination||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|5962|https://civicdb.org/links/evidence/5962|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Laryngeal_Squamous_Cell_Carcinoma_(DOID_2876)|Vemurafenib_(NCIt_ID_C64768)|||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1127|https://civicdb.org/links/evidence/1127|21663470_(PubMed)|Somatic|accepted|Positive|Supports|Hairy_Cell_Leukemia_(DOID_285)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3786|https://civicdb.org/links/evidence/3786|25092772_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Pleomorphic_Xanthoastrocytoma_(DOID_4852)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2134|https://civicdb.org/links/evidence/2134|16424035_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Trametinib_(NCIt_ID_C77908)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3750|https://civicdb.org/links/evidence/3750|23569304_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3747|https://civicdb.org/links/evidence/3747|20149136_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2123|https://civicdb.org/links/evidence/2123|16424035_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Sorafenib_(NCIt_ID_C61948)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|757|https://civicdb.org/links/evidence/757|25370471_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Pictilisib|||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|8506|https://civicdb.org/links/evidence/8506|22180495_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)&Vemurafenib_(NCIt_ID_C64768)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7453|https://civicdb.org/links/evidence/7453|172039_(ASCO)|Somatic|submitted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2142|https://civicdb.org/links/evidence/2142|16533790_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Cancer_(DOID_1781)|Sorafenib_(NCIt_ID_C61948)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|7762|https://civicdb.org/links/evidence/7762|145877_(ASCO)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1421|https://civicdb.org/links/evidence/1421|25265494_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Cobimetinib_(NCIt_ID_C68923)&Vemurafenib_(NCIt_ID_C64768)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|1589|https://civicdb.org/links/evidence/1589|27325282_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Vemurafenib_(NCIt_ID_C64768)|Combination||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3743|https://civicdb.org/links/evidence/3743|23406047_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Thyroid_Gland_Anaplastic_Carcinoma_(DOID_0080522)|Radiation_Therapy_(NCIt_ID_C15313)&Vemurafenib_(NCIt_ID_C64768)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|2137|https://civicdb.org/links/evidence/2137|18682506_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3762|https://civicdb.org/links/evidence/3762|22038996_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|High_Grade_Glioma_(DOID_3070)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|evidence|3751|https://civicdb.org/links/evidence/3751|18287029_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|assertion|20|https://civicdb.org/links/assertion/20||Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)|||||||Tier_I_-_Level_A|Colon_Cancer_(v2.2017)||True,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|assertion|10|https://civicdb.org/links/assertion/10||Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Cobimetinib_(NCIt_ID_C68923)&Vemurafenib_(NCIt_ID_C64768)|Combination|||||Tier_I_-_Level_A|Melanoma_(v2.2018)|True|True,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|assertion|7|https://civicdb.org/links/assertion/7||Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination|||||Tier_I_-_Level_A|Melanoma_(v2.2018)|True|True,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU|NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA|CA123643|13961&376069|1203.5|assertion|23|https://civicdb.org/links/assertion/23||Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Binimetinib_(NCIt_ID_C84865)&Encorafenib_(NCIt_ID_C98283)&Cetuximab_(NCIt_ID_C1723)|Combination||||||Colon/Rectal_Cancer_(vVersion_1.2019)||
8	38274849	515	G	T	.	.	GN=FGFR1;VT=N546K;CSQ=T|missense_variant|FGFR1|2260|transcript|ENST00000341462.5|ENST00000341462.5:c.1638C>A||N546K|515|ASN546LYS&RS779707422|NM\x5F023110\x2E2\x3Ac\x2E1638C\x3EA&NP\x5F075598\x2E2\x3Ap\x2EAsn546Lys&ENST00000341462\x2E5\x3Ac\x2E1638C\x3EA&NC\x5F000008\x2E10\x3Ag\x2E38274849G\x3ET|CA357830|224896|0.5|evidence|1246|https://civicdb.org/links/evidence/1246|26179511_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ewing_Sarcoma_Of_Bone_(DOID_3368)|Ponatinib_(NCIt_ID_C95777)|||E|2|||||
9	133748283	2	C	T	.	.	GN=ABL1;VT=BCR-ABL_T315I;CSQ=T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|234|https://civicdb.org/links/evidence/234|20537386_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||B|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|235|https://civicdb.org/links/evidence/235|15194504_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|1390|https://civicdb.org/links/evidence/1390|23190221_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Ponatinib_(NCIt_ID_C95777)|||B|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|2667|https://civicdb.org/links/evidence/2667|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|2668|https://civicdb.org/links/evidence/2668|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|2669|https://civicdb.org/links/evidence/2669|15930265_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|2672|https://civicdb.org/links/evidence/2672|24180494_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Ponatinib_(NCIt_ID_C95777)|||B|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|2673|https://civicdb.org/links/evidence/2673|19878872_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Ponatinib_(NCIt_ID_C95777)|||D|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4361|https://civicdb.org/links/evidence/4361|19075254_(PubMed)|Somatic|submitted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||D|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4362|https://civicdb.org/links/evidence/4362|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4364|https://civicdb.org/links/evidence/4364|21865346_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4365|https://civicdb.org/links/evidence/4365|19779040_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4366|https://civicdb.org/links/evidence/4366|26118315_(PubMed)|Somatic|submitted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4367|https://civicdb.org/links/evidence/4367|26912052_(PubMed)|Somatic|submitted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4368|https://civicdb.org/links/evidence/4368|27485109_(PubMed)|Somatic|submitted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4369|https://civicdb.org/links/evidence/4369|25686603_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||C|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4370|https://civicdb.org/links/evidence/4370|26239229_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4371|https://civicdb.org/links/evidence/4371|26582647_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4372|https://civicdb.org/links/evidence/4372|26912052_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4373|https://civicdb.org/links/evidence/4373|16775234_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4374|https://civicdb.org/links/evidence/4374|17339191_(PubMed)|Somatic|submitted|Resistance|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Dasatinib_(NCIt_ID_C38713)|||C|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4375|https://civicdb.org/links/evidence/4375|19487385_(PubMed)|Somatic|submitted|Resistance|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Dasatinib_(NCIt_ID_C38713)|||C|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4376|https://civicdb.org/links/evidence/4376|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Dasatinib_(NCIt_ID_C38713)|||C|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4377|https://civicdb.org/links/evidence/4377|19075254_(PubMed)|Somatic|submitted|Resistance|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Dasatinib_(NCIt_ID_C38713)|||D|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4378|https://civicdb.org/links/evidence/4378|15256671_(PubMed)|Somatic|submitted|Resistance|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Dasatinib_(NCIt_ID_C38713)|||D|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|2670|https://civicdb.org/links/evidence/2670|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|6192|https://civicdb.org/links/evidence/6192|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)&Imatinib_Mesylate_(NCIt_ID_C1687)|Combination||D|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|6196|https://civicdb.org/links/evidence/6196|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Nilotinib_(NCIt_ID_C48375)|Combination||D|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|6197|https://civicdb.org/links/evidence/6197|22896000_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Omacetaxine_Mepesuccinate_(NCIt_ID_C1127)|||B|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|6224|https://civicdb.org/links/evidence/6224|19322212_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Omacetaxine_Mepesuccinate_(NCIt_ID_C1127)|||D|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|6234|https://civicdb.org/links/evidence/6234|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Dasatinib_(NCIt_ID_C38713)|Combination||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|6235|https://civicdb.org/links/evidence/6235|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Dasatinib_(NCIt_ID_C38713)|Combination||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|6285|https://civicdb.org/links/evidence/6285|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Nilotinib_(NCIt_ID_C48375)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|6990|https://civicdb.org/links/evidence/6990|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|7038|https://civicdb.org/links/evidence/7038|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|4363|https://civicdb.org/links/evidence/4363|19039322_(PubMed)|Somatic|submitted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|2671|https://civicdb.org/links/evidence/2671|18191450_(PubMed)|Somatic|submitted|Resistance|Supports|Cancer_(DOID_162)|Nilotinib_(NCIt_ID_C48375)&Imatinib_(NCIt_ID_C62035)&Dasatinib_(NCIt_ID_C38713)&Bafetinib_(NCIt_ID_C62516)|Substitutes||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|7777|https://civicdb.org/links/evidence/7777|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Axitinib_(NCIt_ID_C38718)&Ponatinib_(NCIt_ID_C95777)|Substitutes||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|7778|https://civicdb.org/links/evidence/7778|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Nilotinib_(NCIt_ID_C48375)&Imatinib_(NCIt_ID_C62035)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|7779|https://civicdb.org/links/evidence/7779|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Ponatinib_(NCIt_ID_C95777)|||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|7780|https://civicdb.org/links/evidence/7780|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_(NCIt_ID_C62035)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|RS121913459&THR334ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL1\x20THR315ILE&BCR\x2DABL\x20THR315ILE|NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET|CA122575|12624|146.0|evidence|8044|https://civicdb.org/links/evidence/8044|31590170_(PubMed)|Somatic|submitted|Better_Outcome|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)||||B|4|||||
10	89717672	110	C	T	.	.	GN=PTEN;VT=R233*;CSQ=T|stop_gained&loss_of_function_variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.697C>T||R233*|110|RS121909219&ARG233TER&R233X|NM\x5F000314\x2E6\x3Ac\x2E697C\x3ET&NP\x5F000305\x2E3\x3Ap\x2EArg233Ter&ENST00000371953\x2E3\x3Ac\x2E697C\x3ET&NC\x5F000010\x2E10\x3Ag\x2E89717672C\x3ET|CA000549|7813|19.0|evidence|317|https://civicdb.org/links/evidence/317|20085938_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|MTOR_Inhibitor_(NCIt_ID_C2201)|||D|4|||||,T|stop_gained&loss_of_function_variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.697C>T||R233*|110|RS121909219&ARG233TER&R233X|NM\x5F000314\x2E6\x3Ac\x2E697C\x3ET&NP\x5F000305\x2E3\x3Ap\x2EArg233Ter&ENST00000371953\x2E3\x3Ac\x2E697C\x3ET&NC\x5F000010\x2E10\x3Ag\x2E89717672C\x3ET|CA000549|7813|19.0|evidence|343|https://civicdb.org/links/evidence/343|22479427_(PubMed)|Somatic|accepted|Poor_Outcome|Does_Not_Support|Glioblastoma_(DOID_3068)||||B|3|||||
11	108218044	244	A	C	.	.	GN=ATM;VT=N2875H;CSQ=C|missense_variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.8623A>C||N2875H|244|ASN2875HIS&RS1057519869|ENST00000278616\x2E4\x3Ac\x2E8623A\x3EC&NC\x5F000011\x2E9\x3Ag\x2E108218044A\x3EC&NM\x5F000051\x2E3\x3Ac\x2E8623A\x3EC&NP\x5F000042\x2E3\x3Ap\x2EAsn2875His|CA16602795|376353|7.5|evidence|648|https://civicdb.org/links/evidence/648|26510020_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Prostate_Cancer_(DOID_10283)|Olaparib_(NCIt_ID_C71721)|||C|3|||||
12	25398285	78	C	A	.	.	GN=KRAS;VT=G12C;CSQ=A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|1142|https://civicdb.org/links/evidence/1142|26125448_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Docetaxel_(NCIt_ID_C1526)&Selumetinib_(NCIt_ID_C66939)|Combination||B|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|1173|https://civicdb.org/links/evidence/1173|26739882_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|ARS-853&Epidermal_Growth_Factor_Receptor_Tyrosine_Kinase_Inhibitor_(NCIt_ID_C2167)|Combination||D|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|1216|https://civicdb.org/links/evidence/1216|23313110_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Gefitinib_(NCIt_ID_C1855)&Erlotinib_(NCIt_ID_C65530)|Substitutes||B|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3962|https://civicdb.org/links/evidence/3962|16618717_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3963|https://civicdb.org/links/evidence/3963|17998284_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3965|https://civicdb.org/links/evidence/3965|17375050_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3966|https://civicdb.org/links/evidence/3966|18202412_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3967|https://civicdb.org/links/evidence/3967|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Chemotherapy_(NCIt_ID_C15632)|Combination||B|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3968|https://civicdb.org/links/evidence/3968|18946061_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3969|https://civicdb.org/links/evidence/3969|21502544_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3970|https://civicdb.org/links/evidence/3970|19114683_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3971|https://civicdb.org/links/evidence/3971|20010090_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3972|https://civicdb.org/links/evidence/3972|19339720_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3973|https://civicdb.org/links/evidence/3973|26161928_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Regorafenib_(NCIt_ID_C78204)|||D|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3974|https://civicdb.org/links/evidence/3974|23455880_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Sunitinib_(NCIt_ID_C71622)|||D|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3975|https://civicdb.org/links/evidence/3975|27167191_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Palbociclib_(NCIt_ID_C49176)|||D|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3976|https://civicdb.org/links/evidence/3976|16043828_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3977|https://civicdb.org/links/evidence/3977|22982650_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3980|https://civicdb.org/links/evidence/3980|22235099_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3981|https://civicdb.org/links/evidence/3981|24687927_(PubMed)|Somatic|submitted|Resistance|Supports|Colon_Cancer_(DOID_219)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3982|https://civicdb.org/links/evidence/3982|22256804_(PubMed)|Somatic|submitted|Resistance|Supports|Skin_Squamous_Cell_Carcinoma_(DOID_3151)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|3983|https://civicdb.org/links/evidence/3983|26712101_(PubMed)|Somatic|submitted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2253|https://civicdb.org/links/evidence/2253|18316791_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2254|https://civicdb.org/links/evidence/2254|16953233_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2255|https://civicdb.org/links/evidence/2255|2547513_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2256|https://civicdb.org/links/evidence/2256|8462792_(PubMed)|Somatic|submitted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2257|https://civicdb.org/links/evidence/2257|17409929_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Cancer_(DOID_1324)|Gefitinib_(NCIt_ID_C1855)|||B|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2258|https://civicdb.org/links/evidence/2258|19284554_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||B|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2259|https://civicdb.org/links/evidence/2259|11524732_(PubMed)|Somatic|submitted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||B|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2260|https://civicdb.org/links/evidence/2260|15339850_(PubMed)|Somatic|submitted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||B|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2261|https://civicdb.org/links/evidence/2261|11050000_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2262|https://civicdb.org/links/evidence/2262|12483530_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2263|https://civicdb.org/links/evidence/2263|16497971_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|5927|https://civicdb.org/links/evidence/5927|29373830_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|ARS-1620|||D|4|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|2212|https://civicdb.org/links/evidence/2212|22392911_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)&Selumetinib_(NCIt_ID_C66939)|Combination||D|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|7387|https://civicdb.org/links/evidence/7387|31239544_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Sotorasib_(NCIt_ID_C154287)|||B|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|7455|https://civicdb.org/links/evidence/7455|172411_(ASCO)|Somatic|submitted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Sotorasib_(NCIt_ID_C154287)|||B|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|7572|https://civicdb.org/links/evidence/7572|177193_(ASCO)|Somatic|submitted|Sensitivity/Response|Supports|Solid_Tumor|KRAS_G12C_Inhibitor_MRTX849_(NCIt_ID_C157493)|||D|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|8039|https://civicdb.org/links/evidence/8039|31776128_(PubMed)|Somatic|submitted|N/A|Supports|Cancer_(DOID_162)|ARS-1620&Sotorasib_(NCIt_ID_C154287)&SHP2_Inhibitor_RMC-4630_(NCIt_ID_C155850)|Combination||D|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|8068|https://civicdb.org/links/evidence/8068|31666701_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Sotorasib_(NCIt_ID_C154287)|||B|5|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|1217|https://civicdb.org/links/evidence/1217|22247021_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&ENST00000256078\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|91.0|evidence|227|https://civicdb.org/links/evidence/227|23014527_(PubMed)|Somatic|accepted|Positive|Supports|Lung_Cancer_(DOID_1324)||||B|2|||||
13	28592642	56	C	A	.	.	GN=FLT3;VT=TKD_MUTATION;CSQ=A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|171|https://civicdb.org/links/evidence/171|17965322_(PubMed)|Somatic|accepted|Better_Outcome|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|214|https://civicdb.org/links/evidence/214|11290608_(PubMed)|Somatic|accepted|Positive|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|247|https://civicdb.org/links/evidence/247|22368270_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Sorafenib_(NCIt_ID_C61948)|||B|4|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|248|https://civicdb.org/links/evidence/248|18230792_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Sorafenib_(NCIt_ID_C61948)|||B|4|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|322|https://civicdb.org/links/evidence/322|11290608_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|373|https://civicdb.org/links/evidence/373|17940205_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|4|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|1295|https://civicdb.org/links/evidence/1295|20733134_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Midostaurin_(NCIt_ID_C1872)|||B|3|||||
14	105246551	4	C	T	.	.	GN=AKT1;VT=E17K;CSQ=T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&ENST00000407796\x2E2\x3Ac\x2E49G\x3EA|CA123660|13983|32.5|evidence|9007|https://civicdb.org/links/evidence/9007|33377972_(PubMed)|Somatic|submitted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Capivasertib_(NCIt_ID_C102564)|||B|4|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&ENST00000407796\x2E2\x3Ac\x2E49G\x3EA|CA123660|13983|32.5|evidence|231|https://civicdb.org/links/evidence/231|23888070_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Breast_Cancer_(DOID_1612)|Akt_Inhibitor_MK2206_(NCIt_ID_C90581)|||D|3|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&ENST00000407796\x2E2\x3Ac\x2E49G\x3EA|CA123660|13983|32.5|evidence|707|https://civicdb.org/links/evidence/707|24735930_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Uprosertib_(NCIt_ID_C84870)|||D|2|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&ENST00000407796\x2E2\x3Ac\x2E49G\x3EA|CA123660|13983|32.5|evidence|709|https://civicdb.org/links/evidence/709|26351323_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Capivasertib_(NCIt_ID_C102564)|||C|3|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&ENST00000407796\x2E2\x3Ac\x2E49G\x3EA|CA123660|13983|32.5|evidence|3039|https://civicdb.org/links/evidence/3039|28489509_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Capivasertib_(NCIt_ID_C102564)|||B|4|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&ENST00000407796\x2E2\x3Ac\x2E49G\x3EA|CA123660|13983|32.5|evidence|4029|https://civicdb.org/links/evidence/4029|24265155_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||
15	90631838	63	C	T	.	.	GN=IDH2;VT=R172K;CSQ=T|missense_variant|IDH2|3418|transcript|ENST00000330062.3|ENST00000330062.3:c.515G>A||R172K|63|R120K&RS121913503&ARG172LYS|NM\x5F002168\x2E3\x3Ac\x2E515G\x3EA&NP\x5F002159\x2E2\x3Ap\x2EArg172Lys&NC\x5F000015\x2E9\x3Ag\x2E90631838C\x3ET&ENST00000330062\x2E3\x3Ac\x2E515G\x3EA|CA16602462|375987|35.0|evidence|331|https://civicdb.org/links/evidence/331|22616558_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|2|||||,T|missense_variant|IDH2|3418|transcript|ENST00000330062.3|ENST00000330062.3:c.515G>A||R172K|63|R120K&RS121913503&ARG172LYS|NM\x5F002168\x2E3\x3Ac\x2E515G\x3EA&NP\x5F002159\x2E2\x3Ap\x2EArg172Lys&NC\x5F000015\x2E9\x3Ag\x2E90631838C\x3ET&ENST00000330062\x2E3\x3Ac\x2E515G\x3EA|CA16602462|375987|35.0|evidence|332|https://civicdb.org/links/evidence/332|21997850_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Myelodysplastic_Syndrome_(DOID_0050908)||||B|2|||||,T|missense_variant|IDH2|3418|transcript|ENST00000330062.3|ENST00000330062.3:c.515G>A||R172K|63|R120K&RS121913503&ARG172LYS|NM\x5F002168\x2E3\x3Ac\x2E515G\x3EA&NP\x5F002159\x2E2\x3Ap\x2EArg172Lys&NC\x5F000015\x2E9\x3Ag\x2E90631838C\x3ET&ENST00000330062\x2E3\x3Ac\x2E515G\x3EA|CA16602462|375987|35.0|evidence|375|https://civicdb.org/links/evidence/375|21596855_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||
16	69745145	402	G	A	.	.	GN=NQO1;VT=P187S;CSQ=A|missense_variant|NQO1|1728|transcript|ENST00000320623.5|||P187S|402|PRO187SER|NM\x5F000903\x2E2\x3Ac\x2E559C\x3ET&NP\x5F000894\x2E1\x3Ap\x2EPro187Ser&NC\x5F000016\x2E9\x3Ag\x2E69745145G\x3EA|CA126904|16809|2.0|evidence|941|https://civicdb.org/links/evidence/941|21964527_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Lung_Cancer_(DOID_1324)|Amrubicin_(NCIt_ID_C80089)|||D|2|||||
17	7578406	116	C	T	.	.	GN=TP53;VT=R175H;CSQ=T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&ENST00000269305\x2E4\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|389|https://civicdb.org/links/evidence/389|16489069_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&ENST00000269305\x2E4\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|2310|https://civicdb.org/links/evidence/2310|14514923_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Stomach_Carcinoma_(DOID_5517)|EAP_Protocol|||C|None|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&ENST00000269305\x2E4\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|4880|https://civicdb.org/links/evidence/4880|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&ENST00000269305\x2E4\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|319|https://civicdb.org/links/evidence/319|22698404_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&ENST00000269305\x2E4\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|7119|https://civicdb.org/links/evidence/7119|8099841_(PubMed)|Unknown|submitted|Neomorphic|Supports|Cancer_(DOID_162)||||D|4|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&ENST00000269305\x2E4\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|7429|https://civicdb.org/links/evidence/7429|19917135_(PubMed)|Somatic|submitted|Neomorphic|Supports|Endometrial_Cancer_(DOID_1380)||||D|2|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&ENST00000269305\x2E4\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|7112|https://civicdb.org/links/evidence/7112|27589690_(PubMed)|Unknown|submitted|Gain_of_Function|Supports|Cancer_(DOID_162)||||D|3|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&ENST00000269305\x2E4\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|7432|https://civicdb.org/links/evidence/7432|14743206_(PubMed)|Somatic|submitted|Gain_of_Function|Supports|Cancer_(DOID_162)||||D|4|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&ENST00000269305\x2E4\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|7106|https://civicdb.org/links/evidence/7106|27589690_(PubMed)|Unknown|submitted|Loss_of_Function|Supports|Cancer_(DOID_162)||||D|3|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&ENST00000269305\x2E4\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|7526|https://civicdb.org/links/evidence/7526|31395785_(PubMed)|Unknown|submitted|Neomorphic|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||D|4|||||
18	42531913	351	G	A	.	.	GN=SETBP1;VT=G870S;CSQ=A|missense_variant|SETBP1|26040|transcript|ENST00000282030.5|ENST00000282030.5:c.2608G>A||G870S|351|RS267607040&GLY870SER|NM\x5F015559\x2E2\x3Ac\x2E2608G\x3EA&NP\x5F056374\x2E2\x3Ap\x2EGly870Ser&ENST00000282030\x2E5\x3Ac\x2E2608G\x3EA&NC\x5F000018\x2E9\x3Ag\x2E42531913G\x3EA|CA114719|1035|3.0|evidence|840|https://civicdb.org/links/evidence/840|23222956_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)||||D|3|||||
19	44057574	249	G	A	.	.	GN=XRCC1;VT=R194W;CSQ=A|missense_variant|XRCC1|7515|transcript|ENST00000262887.5|ENST00000262887.5:c.580C>T||R194W|249|ARG194TRP&RS1799782|NM\x5F006297\x2E2\x3Ac\x2E580C\x3ET&NP\x5F006288\x2E2\x3Ap\x2EArg194Trp&ENST00000262887\x2E5\x3Ac\x2E580C\x3ET&NC\x5F000019\x2E9\x3Ag\x2E44057574G\x3EA|CA9488737|376355|20.0|evidence|659|https://civicdb.org/links/evidence/659|19157633_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Docetaxel_(NCIt_ID_C1526)&Vinorelbine_(NCIt_ID_C1275)&Gemcitabine_(NCIt_ID_C66876)|Substitutes||B|4|||||
20	57484420	826	C	T	.	.	GN=GNAS;VT=R201C;CSQ=T|missense_variant|GNAS|2778|transcript|ENST00000371085.3|ENST00000371085.3:c.601C>T||R201C|826|R202C&RS11554273&ARG201CYS|NM\x5F000516\x2E5\x3Ac\x2E601C\x3ET&NP\x5F000507\x2E1\x3Ap\x2EArg201Cys&NC\x5F000020\x2E10\x3Ag\x2E57484420C\x3ET&ENST00000371085\x2E3\x3Ac\x2E601C\x3ET|CA126067|15933|5.0|evidence|1906|https://civicdb.org/links/evidence/1906|27729313_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)&Vemurafenib_(NCIt_ID_C64768)|Combination||C|2|||||
21	44514777	127	T	G	.	.	GN=U2AF1;VT=Q157P/R;CSQ=G|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||NC\x5F000021\x2E8\x3Ag\x2E44514777T\x3EG|None||50.0|evidence|400|https://civicdb.org/links/evidence/400|23861105_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Myelodysplastic_Syndrome_(DOID_0050908)||||B|3|||||,G|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||NC\x5F000021\x2E8\x3Ag\x2E44514777T\x3EG|None||50.0|evidence|339|https://civicdb.org/links/evidence/339|23029227_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Myelodysplastic_Syndrome_(DOID_0050908)||||B|2|||||,G|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||NC\x5F000021\x2E8\x3Ag\x2E44514777T\x3EG|None||50.0|evidence|338|https://civicdb.org/links/evidence/338|23029227_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|2|||||,G|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||NC\x5F000021\x2E8\x3Ag\x2E44514777T\x3EG|None||50.0|evidence|217|https://civicdb.org/links/evidence/217|23029227_(PubMed)|Somatic|accepted|Positive|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||
22	30051593	245	T	TT	.	.	GN=NF2;VT=Y177FS;CSQ=T|frameshift_elongation|NF2|4771|transcript|ENST00000338641.4|ENST00000338641.4:c.527_528insT||Y177FS|245|TYR177FS|ENST00000338641\x2E4\x3Ac\x2E527\x5F528insT&NC\x5F000022\x2E10\x3Ag\x2E30051593\x5F30051594insT|CA645601016|NONE_FOUND|7.5|evidence|649|https://civicdb.org/links/evidence/649|25798586_(PubMed)|Somatic|accepted|Resistance|Supports|Peritoneal_Mesothelioma_(DOID_1788)|Cisplatin_(NCIt_ID_C376)&Carboplatin_(NCIt_ID_C1282)|Substitutes||C|3|||||
X	47426121	10	C	G	.	.	GN=ARAF;VT=S214C;CSQ=G|missense_variant|ARAF|369|transcript|ENST00000377045.4|ENST00000377045.4:c.641C>G||S214C|10|SER214CYS&RS1057519786|NC\x5F000023\x2E10\x3Ag\x2E47426121C\x3EG&NM\x5F001654\x2E4\x3Ac\x2E641C\x3EG&NP\x5F001645\x2E1\x3Ap\x2ESer214Cys&ENST00000377045\x2E4\x3Ac\x2E641C\x3EG|CA16602595|376137|11.0|evidence|17|https://civicdb.org/links/evidence/17|24569458_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Sorafenib_(NCIt_ID_C61948)|||C|2|||||,G|missense_variant|ARAF|369|transcript|ENST00000377045.4|ENST00000377045.4:c.641C>G||S214C|10|SER214CYS&RS1057519786|NC\x5F000023\x2E10\x3Ag\x2E47426121C\x3EG&NM\x5F001654\x2E4\x3Ac\x2E641C\x3EG&NP\x5F001645\x2E1\x3Ap\x2ESer214Cys&ENST00000377045\x2E4\x3Ac\x2E641C\x3EG|CA16602595|376137|11.0|evidence|40|https://civicdb.org/links/evidence/40|24569458_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Sorafenib_(NCIt_ID_C61948)|||D|3|||||,G|missense_variant|ARAF|369|transcript|ENST00000377045.4|ENST00000377045.4:c.641C>G||S214C|10|SER214CYS&RS1057519786|NC\x5F000023\x2E10\x3Ag\x2E47426121C\x3EG&NM\x5F001654\x2E4\x3Ac\x2E641C\x3EG&NP\x5F001645\x2E1\x3Ap\x2ESer214Cys&ENST00000377045\x2E4\x3Ac\x2E641C\x3EG|CA16602595|376137|11.0|evidence|41|https://civicdb.org/links/evidence/41|24569458_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Trametinib_(NCIt_ID_C77908)|||D|3|||||
